The Study Will Evaluate if Leuprolide Mesylate is Safe and Effective in the Treatment of Subjects With Advanced Prostate Carcinoma, When Administered as Two Injections Six Months Apart.
Clinical trial NCT06984159 · COMPLETED
Trial details
- NCT number
- NCT06984159
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-12
- Primary completion
- 2023-11-30
- Enrollment
- 137
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.